Ozempic can curb alcohol cravings, study finds
Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption


What happened
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder, researchers reported Wednesday in the journal JAMA Psychiatry. It was the first randomized controlled trial to study the effects of semaglutide on alcohol addiction, though anecdotal evidence and observational and animal studies have suggested the drug curbs desire for alcohol as well as food.
Who said what
The federally funded study gave 48 adults with signs of alcohol use disorder small doses of either semaglutide or a placebo once a week for nine weeks. Those receiving the semaglutide shots consumed significantly less alcohol on the days they drank versus the control group, though both groups drank about the same number of days each week.
"We hoped to see a reduction in drinking and craving," said study lead author Dr. Christian Hendershot of the USC Institute for Addiction Science. But the "magnitude of the effects" was unexpectedly good compared to the three little-used FDA-approved medications for alcohol use disorder. Semaglutide is already popular, and the finding that it helped people drink less could boost treatment uptake, addiction psychiatrist Dr. Raymond Anton said to CNN. "Most people seeking treatment do not want a goal of abstinence for the rest of their lives."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Several larger studies are underway on semaglutide and alcohol, plus the drug's effects on "smokers, people with opioid addiction and cocaine users," The Associated Press said. It's unclear how safe semaglutide "would be for a person of normal weight."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How successful would Elon Musk's third party be?
Today's Big Question Musk has vowed to start a third party after falling out with Trump
-
Music reviews: Bruce Springsteen and Benson Boone
Feature "Tracks II: The Lost Albums" and "American Heart"
-
Why passkeys are the next frontier in digital security
A disruptive new technology promises to put passwords to bed forever — but not yet
-
Deadly fungus tied to a pharaoh's tomb may help fight cancer
Under the radar A once fearsome curse could be a blessing
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Climate change can impact our gut health
Under the radar The gastrointestinal system is being gutted
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
Orthorexia nervosa: when clean eating goes too far
The Explainer Being healthy is fine, but obsessing over it is dangerous
-
Children's breakfast cereals are getting more unhealthy
Under the radar Your kids may be starting their day with more than a spoonful of sugar
-
A happy gut is a healthy gut. These 5 tips aim to help you achieve that goal.
The Week Recommends A healthy gut is all the rage in wellness circles
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials